Location & dates EMBL Heidelberg, Germany 16 - 19 Sep 2018 Register Now
Deadlines Registration - 5 Aug 2018 Abstract submission closed
EES_logo

Preliminary Programme

Got something to say? Tweet it! #EESmicrobiome

Day 1 - Sunday 16 September 2018
TimeSpeaker
12:00 - 14:00

Arrival and registration

14:00 Welcome and opening remarks

Session 1: Microbiome Technologies
Chair: tbc

Multi'omics in microbiome population studies
Curtis Huttenhower - Harvard University, USA

Mapping the mammalian microbiome in 3D
Rob Knight - University of California San Diego, USA

Mapping the human oral microbiome at the micron scale
Gary Borisy - Forsyth Institute, USA

Selected short talks
Day 2 - Monday 17 September 2018
TimeSpeaker
 

Session 2: Challenges in Microbiome Bioinformatics
Chair: tbc

Identifying subgenomic variation across the gut microbiota and unraveling its role in host metabolic health
Eran Segal - Weizmann Institute of Science, Israel

Critical assessment of metagenome interpretation
Alice McHardy - Helmholtz Centre for Infection Research, Germany

Resolving de novo strain variation from metagenomes for high resolution analysis of the human microbiome
Christopher Quince - University of Warwick, UK

Selected short talks

Session 3: Host-microbiome Interactions
Chair: tbc

Social microbes: microbiome as a key regulator of brain and behaviour
John Cryan - University College Cork, Ireland

The human virome in health and disease
Frederic Bushman - University of Pennsylvania, USA

Disentangling host and microbiome contributions to drug metabolism
Andrew Goodman - Yale University, USA

Skin microbiome-host interactions: contributions to skin defense, inflammation and repair
Elizabeth Grice - University of Pennsylvania, USA

Selected short talks
Day 3 - Tuesday 18 September 2018
TimeSpeaker
 

Session 4: Microbiome in Nutrition and Metabolism
Chair: tbc

Tackling metabolic health through diet-microbiome-host alliances
Yolanda Sanz Herranz - Spanish National Research Council, Spain

The gut microbiome is an environmental factor contributing to type 2 diabetes
Fredrik Bäckhed - University of Gothenburg, Sweden
Selected short talks

Session 5: Microbiome-mediated Therapies
Chair: tbc

Talk title to be announced
Laurence Zitvogel - Institut Gustave Roussy, France

Identification of novel beneficial microbes: from the bench to the bedside
Patrice Cani - Université catholique de Louvain and WELBIO, Belgium

Using FMT to dissect causality in human cardiometabolic disease: from lead to cure
Max Nieuwdorp - Academic Medical Center, The Netherlands

Selected short talks
Day 4 - Wednesday 19 September 2018
TimeSpeaker
 

Session 6: Human Microbiome and Infections
Chair: tbc

Microbiota-mediated defense against infection with antibiotic-resistant intestinal pathogens
Eric Pamer - Memorial Sloan Kettering Cancer Center, USA

Microbial interactions in HIV infection
Nichole Klatt - University of Washington, USA

Nose picking for progress: mining the nasal microbiome for new insights into pathobionts
Katherine Lemon - Forsyth Institute, USA

Facultative pathogens in human microbiomes – fighting the enemy within
Andreas Peschel - University of Tübingen, Germany

Selected short talks

14:00 Closing remarks and poster prize